Acorda Therapeutics (ACOR) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Loss before taxes: -10.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Loss before taxes: -10.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of $0.07, $0.11 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $127.5 million versus the consensus estimate of $128.33 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
